Compass Therapeutics | Investor Presentation Deck | 40 slides · page 7 of 40
The slide illustrates the mechanism of action of CTX-009 as a bispecific antibody and compares the effects of single-agent anti-VEGF vs anti-DLL4 blockade.
Pitch deck · solution · present_solution · dense density
Slide locked Sign in to view
Slide schematic 5/5
callout 1/1 diagram 1/1 image 1/1 list 1/1 title 1/1
Components 5
primary process illustration bullet headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.